Anlotinib for Advanced and Refractory Natural Killer /T-cell Lymphoma
Clinical trial NCT03618238 · COMPLETED
Trial details
- NCT number
- NCT03618238
- Sponsor
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-25
- Primary completion
- 2021-04-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.